Product/Composition:- | Bicalutamide |
---|---|
Strength:- | 50 mg , 150 mg |
Form:- | Tablets |
Reference Brands:- | Casodex®(US & EU) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Bicalutamide is an oral anti-androgen used in prostate cancer treatment, available as 50 mg and 150 mg tablets in the US and EU.
Bicalutamide Tablets, available in 50 mg and 150 mg strengths, are widely used in the treatment of prostate cancer in both the US and EU. As a non-steroidal anti-androgen, Bicalutamide inhibits androgen receptors to block testosterone-driven cancer growth, making it an essential part of combination therapy with LHRH analogs or as monotherapy. Marketed under brands like Casodex®, it is a globally trusted oncology drug. Bicalutamide is manufactured under GMP conditions, ideal for B2B pharmaceutical sourcing, contract manufacturing, and global distribution. Its high stability and oral dosage form make it a preferred API for regulated markets. 🧾 Short Description